Cargando…
Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer
Background: Tumor dormancy is an important way to develop drug resistance. This study aimed to identify the characteristics of colorectal cancer (CRC) cell dormancy. Methods: Based on the CRC cohorts, a total of 1,044 CRC patients were included in this study, and divided into a dormant subgroup and...
Autores principales: | Xie, Lang, Huang, Renli, Huang, Hongyun, Liu, Xiaoxia, Yu, Jinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024109/ https://www.ncbi.nlm.nih.gov/pubmed/35462906 http://dx.doi.org/10.3389/fphar.2022.879751 |
Ejemplares similares
-
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Tadalafil in Colorectal Cancer
por: Zhao, Pan, et al.
Publicado: (2022) -
CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer In Vitro Relies on Translational Regulation of CSAG2
por: Zhang, Yaqing, et al.
Publicado: (2021) -
Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma
por: Shou, Qiyang, et al.
Publicado: (2019) -
Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023) -
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Shikonin in Colon Cancer
por: Chen, Yang, et al.
Publicado: (2020)